Avinger-healthcare_professionals-hero-mobile Avinger-healthcare_professionals-hero-tablet
healthcare_professionals

Your decisions today help build the future

banner-img07

Healthcare Professionals

Lumivascular technology is radically changing the way vascular disease is treated. Through the CONNECT II and VISION trial, we were able to receive FDA clearance on both our CTO crossing catheter (Ocelot) and atherectomy catheter (Pantheris). Being able to see inside the artery with Optical Coherence Tomography (OCT) while performing the procedure is a real game changer. It allows the operator to make informed decisions for long term results while leaving normal arterial layers behind.

See Case Studies

Clinical trials prove safety.

Gathering information through seeing inside the artery while performing the procedure may allow for better long term outcomes when you don’t disturb healthy layers of the artery. The data below shows the importance of visualization inside the artery.

vision ide 6 month
lumivascular ATHERECTOMY

130 PATIENTS | 20 SITES | 164 LESIONS | PRIMARY COHORT

LUMINAL GAIN | 72%

  • 79%

    PRE-STENOSIS

  • 30%

    PANTHERIS STANDALONE

  • 22%

    POST-PANTHERIS +/- ADJUNCTIVE THERAPY

adventitia analysis

Adventitia

EFFICACY

Dissections

Safety

Perforations

follow-up data
lumivascular ATHERECTOMY

freedom from tlr

SOURCE: VISION (FULL COHORT, BY LESION)

  • 83%

    12 MONTH (N=89)

  • 77%

    18 MONTH (N=79)

  • 76%

    24 MONTH (N=72)

FREEDOM FROM TLR & PRIMARY PATENCY*

SOURCE: EUROPEAN CASE SERIES (GRAZ, AUSTRIA) BY LESION

  • 88%

    FREEDOM FROM TLR (12 MONTH) (N=33)

  • 86%

    PRIMARY PATENCY (12 MONTH) (N=33)

* Patency is defined as PSVR < 2.4

CONNECT II DATA
LUMIVASCULAR CTO CROSSING

100 PATIENTS | 14 SITES | 100 LESIONS

Efficacy
Safety

LUMINAL CROSSING

  • 93%

    93% = TRUE LUMEN

  • 7%

    7% - SUBINTIMAL

banner-img06

Case Studies

View cases performed by your peers and colleagues in lesions below the knee, above the knee, CTOs, and more. These cases help show how Ocelot and Pantheris are changing the way operators see and perform procedures.

view case studies

Events with Avinger

Visit Avinger at the following upcoming events to learn more on how Lumivascular is radically changing the way vascular disease is treated.

Past events